nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE11A—epithelium—stomach cancer	0.0331	0.192	CbGeAlD
Tadalafil—PDE5A—blood vessel—stomach cancer	0.0259	0.15	CbGeAlD
Tadalafil—PDE11A—endocrine gland—stomach cancer	0.0208	0.121	CbGeAlD
Tadalafil—PDE11A—liver—stomach cancer	0.0188	0.109	CbGeAlD
Tadalafil—PDE5A—hematopoietic system—stomach cancer	0.0138	0.0801	CbGeAlD
Tadalafil—PDE5A—epithelium—stomach cancer	0.0126	0.0732	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—stomach cancer	0.0121	0.0706	CbGeAlD
Tadalafil—PDE5A—digestive system—stomach cancer	0.00958	0.0557	CbGeAlD
Tadalafil—PDE5A—endocrine gland—stomach cancer	0.00791	0.046	CbGeAlD
Tadalafil—PDE5A—lymph node—stomach cancer	0.00547	0.0318	CbGeAlD
Tadalafil—CYP3A4—hematopoietic system—stomach cancer	0.00429	0.025	CbGeAlD
Tadalafil—CYP3A4—digestive system—stomach cancer	0.00299	0.0174	CbGeAlD
Tadalafil—CYP3A4—endocrine gland—stomach cancer	0.00247	0.0143	CbGeAlD
Tadalafil—CYP3A4—liver—stomach cancer	0.00222	0.0129	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS3—stomach cancer	0.00166	0.0401	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—stomach cancer	0.00148	0.0357	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—PPP2R1A—stomach cancer	0.00117	0.0281	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—PPP2R1A—stomach cancer	0.00104	0.025	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—ADRB1—stomach cancer	0.00101	0.0244	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—ADRB2—stomach cancer	0.000822	0.0198	CbGpPWpGaD
Tadalafil—Tachycardia—Docetaxel—stomach cancer	0.000781	0.000993	CcSEcCtD
Tadalafil—Skin disorder—Docetaxel—stomach cancer	0.000777	0.000988	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000776	0.000987	CcSEcCtD
Tadalafil—Oedema—Capecitabine—stomach cancer	0.000775	0.000985	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—stomach cancer	0.00077	0.000978	CcSEcCtD
Tadalafil—Infection—Capecitabine—stomach cancer	0.00077	0.000978	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—stomach cancer	0.000767	0.000976	CcSEcCtD
Tadalafil—Dizziness—Irinotecan—stomach cancer	0.000765	0.000973	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—stomach cancer	0.000763	0.000971	CcSEcCtD
Tadalafil—Shock—Capecitabine—stomach cancer	0.000762	0.000969	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—stomach cancer	0.000762	0.000968	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—stomach cancer	0.000761	0.000968	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—stomach cancer	0.000761	0.000968	CcSEcCtD
Tadalafil—Nervous system disorder—Capecitabine—stomach cancer	0.00076	0.000966	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—stomach cancer	0.00076	0.000966	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—stomach cancer	0.000759	0.000964	CcSEcCtD
Tadalafil—Diarrhoea—Fluorouracil—stomach cancer	0.000758	0.000964	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—stomach cancer	0.000757	0.000962	CcSEcCtD
Tadalafil—Tachycardia—Capecitabine—stomach cancer	0.000756	0.000961	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—stomach cancer	0.000756	0.000961	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—stomach cancer	0.000754	0.000959	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—stomach cancer	0.000753	0.000958	CcSEcCtD
Tadalafil—Skin disorder—Capecitabine—stomach cancer	0.000752	0.000957	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—stomach cancer	0.000751	0.000954	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—stomach cancer	0.00075	0.000954	CcSEcCtD
Tadalafil—Hyperhidrosis—Capecitabine—stomach cancer	0.000749	0.000952	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—stomach cancer	0.000748	0.000951	CcSEcCtD
Tadalafil—Hypotension—Docetaxel—stomach cancer	0.000748	0.000951	CcSEcCtD
Tadalafil—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.000747	0.018	CbGpPWpGaD
Tadalafil—Haematuria—Doxorubicin—stomach cancer	0.000746	0.000949	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—stomach cancer	0.000746	0.000949	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—stomach cancer	0.000745	0.000947	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—stomach cancer	0.000738	0.000939	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—stomach cancer	0.000736	0.000936	CcSEcCtD
Tadalafil—Vomiting—Irinotecan—stomach cancer	0.000736	0.000936	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—stomach cancer	0.000733	0.000932	CcSEcCtD
Tadalafil—Dizziness—Fluorouracil—stomach cancer	0.000733	0.000932	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—stomach cancer	0.000732	0.00093	CcSEcCtD
Tadalafil—Rash—Irinotecan—stomach cancer	0.00073	0.000928	CcSEcCtD
Tadalafil—Dermatitis—Irinotecan—stomach cancer	0.000729	0.000927	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000729	0.000927	CcSEcCtD
Tadalafil—Headache—Irinotecan—stomach cancer	0.000725	0.000922	CcSEcCtD
Tadalafil—Hypotension—Capecitabine—stomach cancer	0.000724	0.00092	CcSEcCtD
Tadalafil—Insomnia—Docetaxel—stomach cancer	0.000724	0.00092	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—stomach cancer	0.000718	0.000913	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—stomach cancer	0.000718	0.000913	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—stomach cancer	0.000713	0.000907	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—stomach cancer	0.000711	0.000904	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—stomach cancer	0.000711	0.000904	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—stomach cancer	0.00071	0.000903	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—stomach cancer	0.000708	0.0009	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—stomach cancer	0.000706	0.000898	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000706	0.000897	CcSEcCtD
Tadalafil—Flushing—Epirubicin—stomach cancer	0.000705	0.000896	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—stomach cancer	0.000705	0.000896	CcSEcCtD
Tadalafil—Vomiting—Fluorouracil—stomach cancer	0.000705	0.000896	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—stomach cancer	0.000705	0.000896	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—stomach cancer	0.000704	0.000895	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—stomach cancer	0.000703	0.000894	CcSEcCtD
Tadalafil—Insomnia—Capecitabine—stomach cancer	0.000701	0.000891	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—stomach cancer	0.000699	0.000889	CcSEcCtD
Tadalafil—Rash—Fluorouracil—stomach cancer	0.000699	0.000889	CcSEcCtD
Tadalafil—Dermatitis—Fluorouracil—stomach cancer	0.000698	0.000888	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—stomach cancer	0.000698	0.000887	CcSEcCtD
Tadalafil—Paraesthesia—Capecitabine—stomach cancer	0.000696	0.000884	CcSEcCtD
Tadalafil—Headache—Fluorouracil—stomach cancer	0.000694	0.000883	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—stomach cancer	0.000694	0.000882	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—stomach cancer	0.000692	0.00088	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000691	0.000878	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—stomach cancer	0.000691	0.000878	CcSEcCtD
Tadalafil—Dyspnoea—Capecitabine—stomach cancer	0.000691	0.000878	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—stomach cancer	0.00069	0.000877	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—stomach cancer	0.000689	0.000876	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—stomach cancer	0.000689	0.000876	CcSEcCtD
Tadalafil—Nausea—Irinotecan—stomach cancer	0.000687	0.000874	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—stomach cancer	0.000686	0.000872	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—stomach cancer	0.000685	0.00087	CcSEcCtD
Tadalafil—Pain—Docetaxel—stomach cancer	0.000684	0.00087	CcSEcCtD
Tadalafil—Constipation—Docetaxel—stomach cancer	0.000684	0.00087	CcSEcCtD
Tadalafil—Back pain—Methotrexate—stomach cancer	0.000683	0.000869	CcSEcCtD
Tadalafil—Dyspepsia—Capecitabine—stomach cancer	0.000682	0.000867	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SERPINB2—stomach cancer	0.000677	0.0163	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000669	0.00085	CcSEcCtD
Tadalafil—Fatigue—Capecitabine—stomach cancer	0.000668	0.000849	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—stomach cancer	0.000666	0.000847	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—stomach cancer	0.000665	0.000846	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—stomach cancer	0.000665	0.000845	CcSEcCtD
Tadalafil—Pain—Capecitabine—stomach cancer	0.000662	0.000842	CcSEcCtD
Tadalafil—Constipation—Capecitabine—stomach cancer	0.000662	0.000842	CcSEcCtD
Tadalafil—Nausea—Fluorouracil—stomach cancer	0.000658	0.000837	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—stomach cancer	0.000657	0.000835	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—stomach cancer	0.000655	0.000833	CcSEcCtD
Tadalafil—Gastrointestinal pain—Docetaxel—stomach cancer	0.000654	0.000832	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—stomach cancer	0.000652	0.000829	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—stomach cancer	0.000652	0.000829	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS3—stomach cancer	0.000648	0.0156	CbGpPWpGaD
Tadalafil—Back pain—Epirubicin—stomach cancer	0.00064	0.000813	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—stomach cancer	0.000638	0.000811	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—stomach cancer	0.000636	0.000808	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—stomach cancer	0.000635	0.000807	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—stomach cancer	0.000635	0.000807	CcSEcCtD
Tadalafil—Gastrointestinal pain—Capecitabine—stomach cancer	0.000633	0.000805	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—stomach cancer	0.000633	0.000805	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—stomach cancer	0.000632	0.000804	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—stomach cancer	0.000623	0.000792	CcSEcCtD
Tadalafil—Cough—Methotrexate—stomach cancer	0.000617	0.000784	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—stomach cancer	0.000616	0.000783	CcSEcCtD
Tadalafil—Urticaria—Capecitabine—stomach cancer	0.000615	0.000782	CcSEcCtD
Tadalafil—Abdominal pain—Capecitabine—stomach cancer	0.000612	0.000779	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—stomach cancer	0.000612	0.000778	CcSEcCtD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.000605	0.0146	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINB2—stomach cancer	0.000604	0.0145	CbGpPWpGaD
Tadalafil—Chest pain—Methotrexate—stomach cancer	0.000602	0.000765	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—stomach cancer	0.000602	0.000765	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—stomach cancer	0.000602	0.000765	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000597	0.00076	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—stomach cancer	0.000594	0.000756	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—stomach cancer	0.000594	0.000755	CcSEcCtD
Tadalafil—Syncope—Epirubicin—stomach cancer	0.000593	0.000754	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—stomach cancer	0.000592	0.000752	CcSEcCtD
Tadalafil—Hypersensitivity—Docetaxel—stomach cancer	0.000589	0.000749	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—stomach cancer	0.000588	0.000748	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—stomach cancer	0.000584	0.000743	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—stomach cancer	0.000581	0.000739	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—ITGA5—stomach cancer	0.000581	0.014	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS3—stomach cancer	0.000578	0.0139	CbGpPWpGaD
Tadalafil—Cough—Epirubicin—stomach cancer	0.000577	0.000734	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—stomach cancer	0.000577	0.000733	CcSEcCtD
Tadalafil—Asthenia—Docetaxel—stomach cancer	0.000574	0.00073	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—stomach cancer	0.000573	0.000728	CcSEcCtD
Tadalafil—Infection—Methotrexate—stomach cancer	0.000573	0.000728	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—stomach cancer	0.000571	0.000726	CcSEcCtD
Tadalafil—Hypersensitivity—Capecitabine—stomach cancer	0.000571	0.000726	CcSEcCtD
Tadalafil—Pruritus—Docetaxel—stomach cancer	0.000566	0.00072	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—stomach cancer	0.000566	0.000719	CcSEcCtD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000564	0.0136	CbGpPWpGaD
Tadalafil—Myalgia—Epirubicin—stomach cancer	0.000563	0.000716	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—stomach cancer	0.000563	0.000716	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—stomach cancer	0.000563	0.000716	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—stomach cancer	0.00056	0.000712	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000559	0.000711	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—stomach cancer	0.000557	0.000709	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—stomach cancer	0.000556	0.000707	CcSEcCtD
Tadalafil—Asthenia—Capecitabine—stomach cancer	0.000556	0.000707	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—stomach cancer	0.000551	0.0007	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—KISS1R—stomach cancer	0.00055	0.0133	CbGpPWpGaD
Tadalafil—Vertigo—Doxorubicin—stomach cancer	0.00055	0.000699	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—stomach cancer	0.000549	0.000698	CcSEcCtD
Tadalafil—Pruritus—Capecitabine—stomach cancer	0.000548	0.000697	CcSEcCtD
Tadalafil—Diarrhoea—Docetaxel—stomach cancer	0.000547	0.000696	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—stomach cancer	0.000541	0.000687	CcSEcCtD
Tadalafil—Oedema—Epirubicin—stomach cancer	0.00054	0.000686	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—stomach cancer	0.000539	0.000685	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—stomach cancer	0.000538	0.000684	CcSEcCtD
Tadalafil—Infection—Epirubicin—stomach cancer	0.000536	0.000682	CcSEcCtD
Tadalafil—Cough—Doxorubicin—stomach cancer	0.000534	0.000679	CcSEcCtD
Tadalafil—Shock—Epirubicin—stomach cancer	0.000531	0.000675	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—stomach cancer	0.00053	0.000674	CcSEcCtD
Tadalafil—Diarrhoea—Capecitabine—stomach cancer	0.00053	0.000674	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—stomach cancer	0.000529	0.000673	CcSEcCtD
Tadalafil—Dizziness—Docetaxel—stomach cancer	0.000529	0.000673	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—stomach cancer	0.000528	0.000672	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—stomach cancer	0.000527	0.00067	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000525	0.000668	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—stomach cancer	0.000524	0.000666	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—stomach cancer	0.000522	0.000663	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—stomach cancer	0.000522	0.000663	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—stomach cancer	0.000521	0.000662	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—stomach cancer	0.000521	0.000662	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—stomach cancer	0.000521	0.000662	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—ITGA5—stomach cancer	0.000518	0.0125	CbGpPWpGaD
Tadalafil—Paraesthesia—Methotrexate—stomach cancer	0.000518	0.000658	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000517	0.000658	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—stomach cancer	0.000515	0.000654	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—stomach cancer	0.000514	0.000654	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—stomach cancer	0.000513	0.000652	CcSEcCtD
Tadalafil—Dizziness—Capecitabine—stomach cancer	0.000512	0.000651	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—stomach cancer	0.000509	0.000648	CcSEcCtD
Tadalafil—Vomiting—Docetaxel—stomach cancer	0.000509	0.000647	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—stomach cancer	0.000508	0.000645	CcSEcCtD
Tadalafil—Rash—Docetaxel—stomach cancer	0.000504	0.000641	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—stomach cancer	0.000504	0.000641	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—stomach cancer	0.000504	0.000641	CcSEcCtD
Tadalafil—Headache—Docetaxel—stomach cancer	0.000501	0.000637	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—KISS1R—stomach cancer	0.0005	0.012	CbGpPWpGaD
Tadalafil—Oedema—Doxorubicin—stomach cancer	0.000499	0.000635	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000498	0.000633	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—stomach cancer	0.000497	0.000632	CcSEcCtD
Tadalafil—Infection—Doxorubicin—stomach cancer	0.000496	0.000631	CcSEcCtD
Tadalafil—Pain—Methotrexate—stomach cancer	0.000493	0.000627	CcSEcCtD
Tadalafil—Vomiting—Capecitabine—stomach cancer	0.000493	0.000626	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000492	0.000625	CcSEcCtD
Tadalafil—Shock—Doxorubicin—stomach cancer	0.000491	0.000625	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—stomach cancer	0.00049	0.000623	CcSEcCtD
Tadalafil—Rash—Capecitabine—stomach cancer	0.000488	0.000621	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—stomach cancer	0.000488	0.000621	CcSEcCtD
Tadalafil—Dermatitis—Capecitabine—stomach cancer	0.000488	0.00062	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—stomach cancer	0.000487	0.00062	CcSEcCtD
Tadalafil—Headache—Capecitabine—stomach cancer	0.000485	0.000617	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—stomach cancer	0.000485	0.000617	CcSEcCtD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000485	0.0117	CbGpPWpGaD
Tadalafil—Paraesthesia—Epirubicin—stomach cancer	0.000485	0.000616	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—stomach cancer	0.000483	0.000614	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—stomach cancer	0.000481	0.000612	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—stomach cancer	0.00048	0.00061	CcSEcCtD
Tadalafil—Nausea—Docetaxel—stomach cancer	0.000475	0.000604	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—stomach cancer	0.000475	0.000604	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—stomach cancer	0.000472	0.0006	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—stomach cancer	0.000467	0.000593	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000466	0.000592	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—stomach cancer	0.000465	0.000592	CcSEcCtD
Tadalafil—Constipation—Epirubicin—stomach cancer	0.000461	0.000587	CcSEcCtD
Tadalafil—Pain—Epirubicin—stomach cancer	0.000461	0.000587	CcSEcCtD
Tadalafil—Nausea—Capecitabine—stomach cancer	0.00046	0.000585	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—stomach cancer	0.000458	0.000582	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—FGG—stomach cancer	0.000457	0.011	CbGpPWpGaD
Tadalafil—Abdominal pain—Methotrexate—stomach cancer	0.000456	0.00058	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000455	0.000578	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—stomach cancer	0.000452	0.000574	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—THBD—stomach cancer	0.000449	0.0108	CbGpPWpGaD
Tadalafil—Paraesthesia—Doxorubicin—stomach cancer	0.000448	0.00057	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—stomach cancer	0.000445	0.000566	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—stomach cancer	0.000444	0.000564	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—stomach cancer	0.000441	0.000561	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—stomach cancer	0.00044	0.000559	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000431	0.000548	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—stomach cancer	0.000431	0.000547	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—stomach cancer	0.000429	0.000545	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—stomach cancer	0.000427	0.000543	CcSEcCtD
Tadalafil—Pain—Doxorubicin—stomach cancer	0.000427	0.000543	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—stomach cancer	0.000427	0.000542	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—stomach cancer	0.000425	0.00054	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PPIA—stomach cancer	0.000415	0.00999	CbGpPWpGaD
Tadalafil—Asthenia—Methotrexate—stomach cancer	0.000414	0.000526	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000408	0.000519	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—stomach cancer	0.000408	0.000519	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—FGG—stomach cancer	0.000408	0.00982	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000405	0.00976	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINA1—stomach cancer	0.0004	0.00963	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—THBD—stomach cancer	0.0004	0.00963	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HRH4—stomach cancer	0.000398	0.00958	CbGpPWpGaD
Tadalafil—Hypersensitivity—Epirubicin—stomach cancer	0.000398	0.000506	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—stomach cancer	0.000397	0.000504	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—stomach cancer	0.000395	0.000502	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—stomach cancer	0.000395	0.000502	CcSEcCtD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.00039	0.00939	CbGpPWpGaD
Tadalafil—Asthenia—Epirubicin—stomach cancer	0.000387	0.000492	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—stomach cancer	0.000382	0.000485	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—stomach cancer	0.000381	0.000485	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PPIA—stomach cancer	0.00037	0.00891	CbGpPWpGaD
Tadalafil—Diarrhoea—Epirubicin—stomach cancer	0.000369	0.000469	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—stomach cancer	0.000368	0.000468	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—stomach cancer	0.000367	0.000466	CcSEcCtD
Tadalafil—Rash—Methotrexate—stomach cancer	0.000364	0.000462	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—stomach cancer	0.000363	0.000462	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—F2R—stomach cancer	0.000362	0.00871	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SPARC—stomach cancer	0.000362	0.00871	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRH4—stomach cancer	0.000361	0.0087	CbGpPWpGaD
Tadalafil—Headache—Methotrexate—stomach cancer	0.000361	0.000459	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—stomach cancer	0.000358	0.000455	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—stomach cancer	0.000357	0.000454	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SERPINA1—stomach cancer	0.000356	0.00858	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—KISS1—stomach cancer	0.000355	0.00854	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IRF1—stomach cancer	0.000354	0.00852	CbGpPWpGaD
Tadalafil—Pruritus—Doxorubicin—stomach cancer	0.000353	0.000449	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—stomach cancer	0.000343	0.000436	CcSEcCtD
Tadalafil—Nausea—Methotrexate—stomach cancer	0.000343	0.000435	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—stomach cancer	0.000342	0.000434	CcSEcCtD
Tadalafil—Rash—Epirubicin—stomach cancer	0.00034	0.000433	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—stomach cancer	0.00034	0.000432	CcSEcCtD
Tadalafil—Headache—Epirubicin—stomach cancer	0.000338	0.00043	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—stomach cancer	0.00033	0.00042	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SPARC—stomach cancer	0.000322	0.00776	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F2R—stomach cancer	0.000322	0.00776	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KISS1—stomach cancer	0.000322	0.00775	CbGpPWpGaD
Tadalafil—Nausea—Epirubicin—stomach cancer	0.000321	0.000408	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.00032	0.00769	CbGpPWpGaD
Tadalafil—Vomiting—Doxorubicin—stomach cancer	0.000317	0.000404	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000316	0.00762	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IRF1—stomach cancer	0.000315	0.00759	CbGpPWpGaD
Tadalafil—Rash—Doxorubicin—stomach cancer	0.000315	0.0004	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—stomach cancer	0.000315	0.0004	CcSEcCtD
Tadalafil—Headache—Doxorubicin—stomach cancer	0.000313	0.000398	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CD44—stomach cancer	0.000307	0.0074	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GAST—stomach cancer	0.000305	0.00734	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RGS2—stomach cancer	0.000305	0.00734	CbGpPWpGaD
Tadalafil—Nausea—Doxorubicin—stomach cancer	0.000297	0.000377	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—KISS1R—stomach cancer	0.000295	0.00711	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GLI3—stomach cancer	0.000295	0.00711	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000284	0.00684	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RBP1—stomach cancer	0.000282	0.00678	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000278	0.0067	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RGS2—stomach cancer	0.000277	0.00667	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAST—stomach cancer	0.000277	0.00667	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CD44—stomach cancer	0.000274	0.0066	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PPP2R1A—stomach cancer	0.000261	0.00629	CbGpPWpGaD
Tadalafil—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000258	0.00621	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PPP2R1A—stomach cancer	0.000233	0.00561	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR2—stomach cancer	0.000231	0.00556	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FYN—stomach cancer	0.00023	0.00555	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—WWOX—stomach cancer	0.00023	0.00553	CbGpPWpGaD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000229	0.00551	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2R—stomach cancer	0.000229	0.0055	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR1A—stomach cancer	0.000222	0.00536	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ANXA1—stomach cancer	0.000215	0.00517	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRH4—stomach cancer	0.000213	0.00514	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—WIF1—stomach cancer	0.000213	0.00514	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR2—stomach cancer	0.00021	0.00505	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADRB1—stomach cancer	0.000208	0.00501	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2R—stomach cancer	0.000208	0.005	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FYN—stomach cancer	0.000205	0.00495	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR1A—stomach cancer	0.000202	0.00486	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKAB1—stomach cancer	0.000197	0.00474	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAU—stomach cancer	0.000197	0.00474	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ANXA1—stomach cancer	0.000195	0.0047	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CAV1—stomach cancer	0.000192	0.00463	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APOA1—stomach cancer	0.000192	0.00461	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KISS1—stomach cancer	0.00019	0.00458	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RNF43—stomach cancer	0.00019	0.00458	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADRB1—stomach cancer	0.000189	0.00455	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCB—stomach cancer	0.000183	0.0044	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAU—stomach cancer	0.000175	0.00422	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CAV1—stomach cancer	0.000171	0.00412	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APOA1—stomach cancer	0.000171	0.00411	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FST—stomach cancer	0.00017	0.00408	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADRB2—stomach cancer	0.000169	0.00406	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000168	0.00405	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000166	0.004	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HBEGF—stomach cancer	0.000166	0.00399	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GAST—stomach cancer	0.000164	0.00394	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RGS2—stomach cancer	0.000164	0.00394	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCB—stomach cancer	0.000163	0.00392	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGG—stomach cancer	0.000155	0.00373	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADRB2—stomach cancer	0.000153	0.00369	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINE1—stomach cancer	0.000152	0.00366	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—stomach cancer	0.000152	0.00366	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP2R1A—stomach cancer	0.00015	0.00361	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKAA1—stomach cancer	0.000149	0.00359	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—RHOA—stomach cancer	0.000147	0.00353	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS3—stomach cancer	0.000145	0.0035	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RBP4—stomach cancer	0.000144	0.00347	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000136	0.00329	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINE1—stomach cancer	0.000136	0.00327	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—stomach cancer	0.000135	0.00326	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—RHOA—stomach cancer	0.000131	0.00315	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS3—stomach cancer	0.000129	0.00312	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HSPB1—stomach cancer	0.000124	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR2—stomach cancer	0.000124	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2R—stomach cancer	0.000123	0.00295	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BMP2—stomach cancer	0.000123	0.00295	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000122	0.00295	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKR1C3—stomach cancer	0.000121	0.0029	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR1A—stomach cancer	0.000119	0.00287	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCB—stomach cancer	0.000116	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ANXA1—stomach cancer	0.000115	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB1—stomach cancer	0.000112	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RPS6—stomach cancer	0.000107	0.00257	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCB—stomach cancer	0.000105	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—stomach cancer	0.000105	0.00252	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6ST—stomach cancer	0.000105	0.00252	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK3—stomach cancer	9.9e-05	0.00238	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HBEGF—stomach cancer	9.8e-05	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK1—stomach cancer	9.42e-05	0.00227	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—stomach cancer	9.33e-05	0.00225	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6R—stomach cancer	9.32e-05	0.00225	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—RHOA—stomach cancer	9.28e-05	0.00223	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB2—stomach cancer	9.04e-05	0.00218	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KRAS—stomach cancer	8.9e-05	0.00214	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP2R1A—stomach cancer	8.86e-05	0.00213	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK3—stomach cancer	8.82e-05	0.00212	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RHOA—stomach cancer	8.42e-05	0.00203	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK1—stomach cancer	8.4e-05	0.00202	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SMAD4—stomach cancer	8.23e-05	0.00198	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—stomach cancer	8.17e-05	0.00197	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—stomach cancer	8.14e-05	0.00196	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KRAS—stomach cancer	7.93e-05	0.00191	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—stomach cancer	7.91e-05	0.0019	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FYN—stomach cancer	7.81e-05	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HRAS—stomach cancer	7.56e-05	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—stomach cancer	7.39e-05	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGFR2—stomach cancer	7.33e-05	0.00177	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—stomach cancer	7.33e-05	0.00177	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—stomach cancer	7.29e-05	0.00175	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	7.25e-05	0.00175	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—stomach cancer	7.05e-05	0.0017	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	6.96e-05	0.00167	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—HRAS—stomach cancer	6.74e-05	0.00162	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IRS2—stomach cancer	6.72e-05	0.00162	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CAV1—stomach cancer	6.51e-05	0.00157	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—stomach cancer	6.5e-05	0.00156	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCB—stomach cancer	6.2e-05	0.00149	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6ST—stomach cancer	6.17e-05	0.00149	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APC—stomach cancer	5.93e-05	0.00143	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK3—stomach cancer	5.68e-05	0.00137	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6R—stomach cancer	5.51e-05	0.00133	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK1—stomach cancer	5.41e-05	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—stomach cancer	5.4e-05	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—stomach cancer	5.17e-05	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—stomach cancer	5.16e-05	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KRAS—stomach cancer	5.11e-05	0.00123	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—stomach cancer	5.08e-05	0.00122	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	5.01e-05	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RHOA—stomach cancer	4.98e-05	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—stomach cancer	4.92e-05	0.00119	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—stomach cancer	4.69e-05	0.00113	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.67e-05	0.00112	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.61e-05	0.00111	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB2—stomach cancer	4.61e-05	0.00111	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACAD8—stomach cancer	4.37e-05	0.00105	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—stomach cancer	4.37e-05	0.00105	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRAS—stomach cancer	4.34e-05	0.00104	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1B—stomach cancer	4.27e-05	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—stomach cancer	4.15e-05	0.001	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCND1—stomach cancer	4.07e-05	0.00098	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JUN—stomach cancer	4.06e-05	0.000978	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—stomach cancer	3.95e-05	0.000951	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1A—stomach cancer	3.94e-05	0.000948	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GMPR2—stomach cancer	3.9e-05	0.000938	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK8—stomach cancer	3.84e-05	0.000925	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—IDH3B—stomach cancer	3.56e-05	0.000858	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.56e-05	0.000858	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—stomach cancer	3.55e-05	0.000854	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—stomach cancer	3.51e-05	0.000846	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK3—stomach cancer	3.36e-05	0.000808	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.31e-05	0.000798	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.31e-05	0.000798	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—stomach cancer	3.26e-05	0.000786	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK1—stomach cancer	3.19e-05	0.000769	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—stomach cancer	3.19e-05	0.000769	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KRAS—stomach cancer	3.02e-05	0.000726	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PGLS—stomach cancer	2.95e-05	0.000711	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BLVRB—stomach cancer	2.95e-05	0.000711	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.82e-05	0.000678	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—stomach cancer	2.77e-05	0.000667	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—stomach cancer	2.68e-05	0.000645	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRAS—stomach cancer	2.56e-05	0.000617	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.51e-05	0.000604	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FBP1—stomach cancer	2.51e-05	0.000604	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA1—stomach cancer	2.51e-05	0.000604	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKB—stomach cancer	2.51e-05	0.000604	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—stomach cancer	2.45e-05	0.000591	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLIN2—stomach cancer	2.36e-05	0.000568	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA2—stomach cancer	2.3e-05	0.000553	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PGAM1—stomach cancer	2.24e-05	0.000539	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NT5E—stomach cancer	2.24e-05	0.000539	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCE1—stomach cancer	2.13e-05	0.000514	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.13e-05	0.000514	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UMPS—stomach cancer	2.05e-05	0.000493	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PDHA1—stomach cancer	1.9e-05	0.000458	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ECHS1—stomach cancer	1.9e-05	0.000458	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FADS1—stomach cancer	1.79e-05	0.000431	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TYMP—stomach cancer	1.79e-05	0.000431	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SREBF2—stomach cancer	1.68e-05	0.000403	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—RORA—stomach cancer	1.66e-05	0.000399	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDOB—stomach cancer	1.55e-05	0.000373	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5—stomach cancer	1.44e-05	0.000347	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DPYD—stomach cancer	1.42e-05	0.000342	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—stomach cancer	1.25e-05	0.000302	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.24e-05	0.000299	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.21e-05	0.00029	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENO1—stomach cancer	1.18e-05	0.000283	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD44—stomach cancer	1.04e-05	0.000251	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.86e-06	0.000213	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—stomach cancer	8.69e-06	0.000209	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—stomach cancer	8.57e-06	0.000206	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TYMS—stomach cancer	8.08e-06	0.000195	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—stomach cancer	7.99e-06	0.000192	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ERCC2—stomach cancer	7.51e-06	0.000181	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—stomach cancer	7.06e-06	0.00017	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—stomach cancer	6.51e-06	0.000157	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—stomach cancer	6.5e-06	0.000156	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—stomach cancer	5.73e-06	0.000138	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—stomach cancer	5.15e-06	0.000124	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—stomach cancer	4.92e-06	0.000119	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—stomach cancer	4.5e-06	0.000108	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.77e-06	6.67e-05	CbGpPWpGaD
